Adagene (ADAG) Total Liabilities (2019 - 2025)
Adagene's (ADAG) quarterly Total Liabilities came in at $26.4 million in Q4 2025, down 31.96% year-on-year from $38.7 million in Q4 2024, and down 7.84% on a QoQ basis from $28.6 million in Q2 2025.
Adagene (ADAG) Total Liabilities (2019 - 2025) Analysis & Trends
Adagene (ADAG) has 7 years of Total Liabilities data on file, last reported at $26.4 million in Q4 2025.
- On a quarterly basis, Total Liabilities fell 31.96% year-over-year to $26.4 million in Q4 2025; TTM through Dec 2025 was $26.4 million, a 31.96% decrease from a year earlier, with the FY2025 full-year figure at $26.4 million, down 31.96% from the prior year.
- Total Liabilities for Q4 2025 stood at $26.4 million, down from $28.6 million in the prior quarter.
- Over the last five years, Total Liabilities for ADAG reached as high as $69.3 million in Q4 2022 and fell as low as $52.51 in Q2 2023.
- Historically, Total Liabilities has averaged $31.7 million across 5 years, with a median of $32.3 million in 2021.
- Across the five-year window, Total Liabilities slumped 100.0% in 2022 and soared 84161154.61% in 2024, its largest moves.
- Year by year, Total Liabilities stood at $33.0 million in 2021, then jumped by 110.33% to $69.3 million in 2022, then tumbled by 34.83% to $45.2 million in 2023, then decreased by 14.22% to $38.7 million in 2024, then plunged by 31.96% to $26.4 million in 2025.
- Per Business Quant data, the three most recent Total Liabilities figures were $26.4 million in Q4 2025, $28.6 million in Q2 2025, and $38.7 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Adagene | 198.85 Mn | 198.85 Mn | - | 26.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.36 Mn |
| Jun 30, 2025 | 28.60 Mn |
| Dec 31, 2024 | 38.74 Mn |
| Jun 30, 2024 | 44.19 Mn |
| Dec 31, 2023 | 45.17 Mn |
| Jun 30, 2023 | 52.51 |
| Dec 31, 2022 | 69.31 Mn |
| Jun 30, 2022 | 65.87 |
| Dec 31, 2021 | 32.95 Mn |
| Jun 30, 2021 | 31.64 Mn |
| Dec 31, 2020 | 19.20 Mn |
| Dec 31, 2019 | 8.70 Mn |